EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
2.4.1.92 | phosphatidylglycerol | stimulates the activity of GM2 synthase without disrupting the vesicular intactness | Rattus norvegicus |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
2.4.1.92 | Golgi apparatus | - |
Rattus norvegicus | 5794 | - |
2.4.3.8 | Golgi apparatus | - |
Rattus norvegicus | 5794 | - |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.4.1.92 | Rattus norvegicus | Q10468 | - |
- |
2.4.3.8 | Rattus norvegicus | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.4.1.92 | liver | - |
Rattus norvegicus | - |
2.4.3.8 | liver | - |
Rattus norvegicus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.1.92 | UDP-N-acetyl-alpha-D-galactosamine + ganglioside GM3 | ganglioside GM3 i.e. 1-O-[O-(N-acetyl-alpha-neuraminyl)-(2->3)-O-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl]-ceramideganglioside | Rattus norvegicus | UDP + ganglioside GM2 | - |
? | |
2.4.1.92 | UDP-N-acetyl-alpha-D-galactosamine + ganglioside GM3 amide | 10% of the activity with ganglioside GM3 | Rattus norvegicus | UDP + ganglioside GM2 amide | - |
? | |
2.4.1.92 | UDP-N-acetyl-alpha-D-galactosamine + ganglioside GM3 methyl ester | 13% of the activity with ganglioside GM3 | Rattus norvegicus | UDP + ganglioside GM2 methyl ester | - |
? | |
2.4.1.92 | UDP-N-acetyl-alpha-D-galactosamine + ganglioside GM3 methylamide | 1% of the activity with ganglioside GM3 | Rattus norvegicus | UDP + ganglioside GM2 methylamide | - |
? | |
2.4.1.92 | UDP-N-acetyl-alpha-D-galactosamine + ganglioside lyso-GM3 | 28% of the activity with ganglioside GM3 | Rattus norvegicus | UDP + ganglioside lyso-GM2 | - |
? | |
2.4.1.92 | UDP-N-acetyl-alpha-D-galactosamine + ganglioside N-acetyl-lyso-GM3 | 160% of the activity with ganglioside GM3 | Rattus norvegicus | UDP + ganglioside N-acetyl-lyso-GM2 | - |
? | |
2.4.1.92 | UDP-N-acetyl-alpha-D-galactosamine + ganglioside N-octanoyl-lyso-GM3 | 122% of the activity with ganglioside GM3 | Rattus norvegicus | UDP + ganglioside N-octanoyl-lyso-GM2 | - |
? | |
2.4.1.92 | UDP-N-acetyl-alpha-D-galactosamine + ganglioside N1-pyrenyl-dodecanoyl-lyso-GM3 | 102% of the activity with ganglioside GM3 | Rattus norvegicus | UDP + ganglioside N1-pyrenyl-dodecanoyl-lyso-GM2 | - |
? | |
2.4.3.8 | CMP-N-acetylneuraminate + ganglioside GM3 | ganglioside GM3 i.e. 1-O-[O-(N-acetyl-alpha-neuraminyl)-(2->3)-O-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl]-ceramideganglioside | Rattus norvegicus | CMP + ganglioside GD3 | - |
? | |
2.4.3.8 | CMP-N-acetylneuraminate + ganglioside GM3 amide | 11% of the activity compared to ganglioside GM3 | Rattus norvegicus | CMP + ganglioside GD3 amide | - |
? | |
2.4.3.8 | CMP-N-acetylneuraminate + ganglioside GM3 methyl ester | 10% of the activity compared to ganglioside GM3 | Rattus norvegicus | CMP + ganglioside GD3 methyl ester | - |
? | |
2.4.3.8 | CMP-N-acetylneuraminate + ganglioside GM3 methylamide | 1% of the activity compared to ganglioside GM3 | Rattus norvegicus | CMP + ganglioside GD3 methylamide | - |
? | |
2.4.3.8 | CMP-N-acetylneuraminate + ganglioside lyso-GM3 | 70% of the activity compared to ganglioside GM3 | Rattus norvegicus | CMP + ganglioside lyso-GD3 | - |
? | |
2.4.3.8 | CMP-N-acetylneuraminate + ganglioside N-acetyl-lyso-GM3 | 120% of the activity compared to ganglioside GM3 | Rattus norvegicus | CMP + ganglioside N-acetyl-lyso-GD3 | - |
? | |
2.4.3.8 | CMP-N-acetylneuraminate + ganglioside N-octanoyl-lyso-GM3 | 101% of the activity compared to ganglioside GM3 | Rattus norvegicus | CMP + ganglioside N-octanoyl-lyso-GD3 | - |
? | |
2.4.3.8 | CMP-N-acetylneuraminate + ganglioside N1-pyrenyl-dodecanoyl-lyso-GM3 | 93% of the activity compared to ganglioside GM3 | Rattus norvegicus | CMP + ganglioside N1-pyrenyl-dodecanoyl-lyso-GD3 | - |
? | |
2.4.3.8 | additional information | substrate specificity is strongly determined by the negative charge of the substrate and the acyl residue in amide bond to the amino group of neuraminic acid | Rattus norvegicus | ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.4.1.92 | GM2 synthase | - |
Rattus norvegicus |
2.4.1.92 | UDP-2-acetamido-2-deoxy-D-galactose:(N-acetylneuraminyl)-D-galactosyl-D-glucosyl-N-acylsphingosine acetamidodeoxygalactosyl-transferase | - |
Rattus norvegicus |
2.4.3.8 | CMP-N-acetylneuraminate: N-acetyl-neuraminyl-D-galactosyl-D-glucosylceramide N-acetylneuraminyl alpha2->8 transferase | - |
Rattus norvegicus |
2.4.3.8 | GD3 synthase | - |
Rattus norvegicus |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
2.4.1.92 | 37 | - |
assay at | Rattus norvegicus |
2.4.3.8 | 37 | - |
assay at | Rattus norvegicus |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
2.4.1.92 | 7.35 | - |
assay at | Rattus norvegicus |